MedTrace Logo

Parafilm to Prevent CLABSI in Pediatric Patients Undergoing HCT

NCT02575079 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 119

Last updated 2019-06-25

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to see if applying parafilm as an external barrier on the central line in children having a bone marrow transplant helps to prevent central line associated bloodstream infection(s) and also to assess the ease of use of parafilm.

Conditions

  • Central Line Associated Bloodstream Infections (CLABSI)
  • Bone Marrow Transplant

Interventions

DEVICE

Parafilm

Single-use, pre-cut sections of parafilm over the central venous catheter (CVC) hub (if not connected) or around the CVC hub connection (if connected). Parafilm will be maintained on the CVC until it is removed.

Sponsors & Collaborators

  • Emory University

    lead OTHER

Principal Investigators

  • Lakshmanan Krishnamurti, MD · Emory University

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2018-03-29
Completion
2018-03-29

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02575079 on ClinicalTrials.gov